Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Avril, Marion ^a   Cartwright, Megan M ^a   Hathaway, Marianne J ^a   Smith, Joseph D ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; MALARIA VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VAR2CSA PROTEIN DUFFY BINDING LIKE 1 DOMAIN; RECOMBINANT VAR2CSA PROTEIN DUFFY BINDING LIKE 3 DOMAIN; RECOMBINANT VAR2CSA PROTEIN DUFFY BINDING LIKE 4 DOMAIN; RECOMBINANT VAR2CSA PROTEIN DUFFY BINDING LIKE 5 DOMAIN; RECOMBINANT VAR2CSA PROTEIN DUFFY BINDING LIKE 6 DOMAIN; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTOZOON ANTIBODY; VAR2CSA PROTEIN, PLASMODIUM FALCIPARUM;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; IMMUNOGENICITY; NONHUMAN; PICHIA PASTORIS; PLASMODIUM FALCIPARUM; PROTEIN DOMAIN; RABBIT; RAT; VACCINATION; ANIMAL; CELL ADHESION; CROSS REACTION; FEMALE; GENETICS; IMMUNOLOGY; MALARIA FALCIPARUM; PARASITOLOGY; PICHIA; PREGNANCY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL ADHESION; CROSS REACTIONS; ERYTHROCYTES; FEMALE; MALARIA VACCINES; MALARIA, FALCIPARUM; PICHIA; PLASMODIUM FALCIPARUM; PREGNANCY; RABBITS; RATS; RECOMBINANT PROTEINS;

EID: 79751525818     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-36     Document Type: Article

References (50)

1. The global distribution of clinical episodes of Plasmodium falciparum malaria. RW Snow CA Guerra AM Noor HY Myint SI Hay, Nature 2005 434 214 217 10.1038/nature03342 15759000 (Pubitemid 40388051)
2. The burden of malaria in pregnancy in malaria-endemic areas. RW Steketee BL Nahlen ME Parise C Menendez, Am J Trop Med Hyg 2001 64 28 35 11425175 (Pubitemid 32552569)
3. The sick placenta-the role of malaria. BJ Brabin C Romagosa S Abdelgalil C Menendez FH Verhoeff R McGready KA Fletcher S Owens U D'Alessandro F Nosten PR Fischer J Ordi, Placenta 2004 25 359 78 10.1016/j.placenta.2003.10.019 15081631
4. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. PA Buffet B Gamain C Scheidig D Baruch JD Smith R Hernandez-Rivas B Pouvelle S Oishi N Fujii T Fusai D Parzy LH Miller J Gysin A Scherf, Proc Natl Acad Sci USA 1999 96 12743 8 10.1073/pnas.96.22.12743 10535993 (Pubitemid 29513573)
5. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. M Fried PE Duffy, Science 1996 272 1502 4 10.1126/science.272.5267. 1502 8633247 (Pubitemid 26200005)
6. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. PE Duffy M Fried, Infect Immun 2003 71 6620 3 10.1128/IAI.71.11.6620- 6623.2003 14573685 (Pubitemid 37337723)
7. Maternal antibodies block malaria. M Fried F Nosten A Brockman BJ Brabin PE Duffy, Nature 1998 395 851 2 10.1038/27570 9804416
8. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. T Staalsoe CE Shulman JN Bulmer K Kawuondo K Marsh L Hviid, Lancet 2004 363 283 9 10.1016/S0140-6736(03)15386-X 14751701 (Pubitemid 38142411)
9. Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria. A Jaworowski LA Fernandes F Yosaatmadja G Feng V Mwapasa ME Molyneux SR Meshnick J Lewis SJ Rogerson, Clin Vaccine Immunol 2009 16 312 319 10.1128/CVI.00356-08 19129467
10. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. J Keen L Serghides K Ayi SN Patel J Ayisi EA van R Steketee V Udhayakumar KC Kain, PLoS Med 2007 4 181 10.1371/journal.pmed.0040181 17535103
11. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. AM Mount V Mwapasa SR Elliott JG Beeson E Tadesse VM Lema ME Molyneux SR Meshnick SJ Rogerson, Lancet 2004 363 1860 7 10.1016/S0140-6736(04)16354-X 15183624 (Pubitemid 38748641)
12. VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. P Magistrado A Salanti NG Tuikue Ndam SB Mwakalinga M Resende M Dahlback L Hviid J Lusingu TG Theander MA Nielsen, J Infect Dis 2008 198 1071 1074 10.1086/591502 18700835
13. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. A Salanti T Staalsoe T Lavstsen AT Jensen MP Sowa DE Arnot L Hviid TG Theander, Mol Microbiol 2003 49 179 91 10.1046/j.1365-2958. 2003.03570.x 12823820 (Pubitemid 36792013)
14. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. MF Duffy AG Maier TJ Byrne AJ Marty SR Elliott MT O'Neill PD Payne SJ Rogerson AF Cowman BS Crabb GV Brown, Mol Biochem Parasitol 2006 148 117 124 10.1016/j.molbiopara.2006.03.006 16631964 (Pubitemid 43946508)
15. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. NK Viebig B Gamain C Scheidig C Lepolard J Przyborski M Lanzer J Gysin A Scherf, EMBO Rep 2005 6 775 781 10.1038/sj.embor.7400466 16025132 (Pubitemid 43108701)
16. Disruption of var2csa gene impairs placental malaria associated adhesion phenotype. NK Viebig E Levin S Dechavanne SJ Rogerson J Gysin JD Smith A Scherf B Gamain, PLoS ONE 2007 2 910 10.1371/journal.pone.0000910 17878945
17. Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. P Andersen MA Nielsen M Resende TS Rask M Dahlback T Theander O Lund A Salanti, PLoS Pathog 2008 4 42 10.1371/journal.ppat.0040042 18282103
18. Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. J Bockhorst F Lu JH Janes J Keebler B Gamain P Awadalla XZ Su R Samudrala N Jojic JD Smith, Mol Biochem Parasitol 2007 155 103 112 10.1016/j.molbiopara.2007.06.007 17669514 (Pubitemid 47238448)
19. Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. AR Trimnell SM Kraemer S Mukherjee DJ Phippard JH Janes E Flamoe XZ Su P Awadalla JD Smith, Mol Biochem Parasitol 2006 148 169 180 10.1016/j.molbiopara.2006.03.012 16697476 (Pubitemid 43946513)
20. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. B Gamain AR Trimnell C Scheidig A Scherf LH Miller JD Smith, J Infect Dis 2005 191 1010 3 10.1086/428137 15717280 (Pubitemid 40349820)
21. Structure of the DBL3× domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. K Singh AG Gittis P Nguyen DC Gowda LH Miller DN Garboczi, Nat Struct Mol Biol 2008 15 932 938 10.1038/nsmb.1479 19172746
22. Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? M Dahlback MA Nielsen A Salanti, Trends Parasitol 2010 26 230 235 10.1016/j.pt.2010.02.002 20189879
23. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites. M Resende SB Ditlev MA Nielsen S Bodevin S Bruun VV Pinto H Clausen L Turner TG Theander A Salanti M Dahlback, Int J Parasitol 2009 39 1195 1204 10.1016/j.ijpara.2009.02. 022 19324047
24. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. P Khunrae M Dahlback MA Nielsen G Andersen SB Ditlev M Resende VV Pinto TG Theander MK Higgins A Salanti, J Mol Biol 2010 397 826 834 10.1016/j.jmb.2010.01.040 20109466
25. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. A Srivastava S Gangnard A Round S Dechavanne A Juillerat B Raynal G Faure B Baron S Ramboarina SK Singh H Belrhali P England A Lewit-Bentley A Scherf GA Bentley B Gamain, Proc Natl Acad Sci USA 2010 107 4884 4889 10.1073/pnas.1000951107 20194779
26. Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes. L Barfod MA Nielsen L Turner M Dahlback AT Jensen L Hviid TG Theander A Salanti, Infect Immun 2006 74 4357 4360 10.1128/IAI.01617-05 16790811 (Pubitemid 43993370)
27. VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein. AV Oleinikov SE Francis JR Dorfman E Rossnagle S Balcaitis T Getz M Avril S Gose JD Smith M Fried PE Duffy, J Infect Dis 2008 197 1119 1123 10.1086/529526 18462161 (Pubitemid 351590047)
28. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites. P Fernandez N Kviebig S Dechavanne C Lepolard J Gysin A Scherf B Gamain, Malar J 2008 7 170 10.1186/1475-2875-7-170 18771584
29. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA. M Avril BR Kulasekara SO Gose C Rowe M Dahlback PE Duffy M Fried A Salanti L Misher DL Narum JD Smith, Infect Immun 2008 76 1791 1800 10.1128/IAI.01470-07 18250177 (Pubitemid 351562025)
30. Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes. M Avril MM Cartwright MJ Hathaway M Hommel SR Elliott K Williamson DL Narum PE Duffy M Fried JG Beeson JD Smith, Infect Immun 2010 78 2248 2256 10.1128/IAI.00410-09 20194590
31. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. MA Nielsen VV Pinto M Resende M Dahlback SB Ditlev TG Theander A Salanti, Infect Immun 2009 77 2482 2487 10.1128/IAI.00159-09 19307213
32. Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies. A Salanti M Resende SB Ditlev VV Pinto M Dahlback G Andersen T Manczak TG Theander MA Nielsen, Malar J 2010 9 11 10.1186/1475-2875-9-11 20064234
33. Strain-transcendent immune response to recombinant Var2CSA DBL5-epsilon domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions. P Fernandez S Petres S Mecheri J Gysin A Scherf, PLoS ONE 2010 5 12558 10.1371/journal.pone.0012558 20838433
34. High efficacy of anti DBL4varepsilon-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. PA Magistrado D Minja J Doritchamou NN Tuikue D John C Schmiegelow A Massougbodji M Dahlback SB Ditlev VV Pinto M Resende J Lusingu TG Theander A Salanti MA Nielsen, Vaccine 2011 29 3 437 43 Epub 2010 Nov 12 10.1016/j.vaccine.2010.10.080 21075162
35. Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris. M Avril MJ Hathaway MM Cartwright SO Gose DL Narum JD Smith, Malar J 2009 8 143 10.1186/1475-2875-8-143 19563628
36. Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. A Scherf R Hernandez-Rivas P Buffet E Bottius C Benatar B Pouvelle J Gysin M Lanzer, Embo J 1998 17 5418 26 10.1093/emboj/17.18.5418 9736619 (Pubitemid 28427055)
37. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults. SR Elliott PD Payne MF Duffy TJ Byrne WH Tham SJ Rogerson GV Brown DP Eisen, Am J Trop Med Hyg 2007 76 860 864 17488905 (Pubitemid 351627669)
38. Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. M Hommel SR Elliott V Soma G Kelly FJ Fowkes JM Chesson MF Duffy J Bockhorst M Avril I Mueller A Raiko DI Stanisic SJ Rogerson JD Smith JG Beeson, Infect Immun 2010 78 1963 1978 10.1128/IAI.01365-09 20160014
39. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. G Snounou X Zhu N Siripoon W Jarra S Thaithong KN Brown S Viriyakosol, Trans R Soc Trop Med Hyg 1999 93 369 374 10.1016/S0035-9203(99)90120-7 10674079 (Pubitemid 29405860)
40. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. G Pasvol RJ Wilson ME Smalley J Brown, Ann Trop Med Parasitol 1978 72 87 88 350172 (Pubitemid 9112070)
41. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. WE Harrington TK Mutabingwa A Muehlenbachs B Sorensen MC Bolla M Fried PE Duffy, Proc Natl Acad Sci USA 2009 106 9027 9032 10.1073/pnas.0901415106 19451638
42. Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission. RF Leke JD Bioga J Zhou GG Fouda RJ Leke V Tchinda R Megnekou J Fogako G Sama P Gwanmesia G Bomback C Nama A Diouf N Bobbili DW Taylor, Am J Trop Med Hyg 2010 83 996 1004 10.4269/ajtmh.2010.10-0249 21036826
43. Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. A Walker-Abbey RR Djokam A Eno RF Leke VP Titanji J Fogako G Sama LH Thuita E Beardslee G Snounou A Zhou DW Taylor, Am J Trop Med Hyg 2005 72 229 235 15772312 (Pubitemid 41278867)
44. Malaria vaccine design: immunological considerations. MF Good DL Doolan, Immunity 2010 33 555 566 10.1016/j.immuni.2010.10.005 21029965
45. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. NH Tolia EJ Enemark BK Sim L Joshua-Tor, Cell 2005 122 183 193 10.1016/j.cell.2005.05.033 16051144 (Pubitemid 41032983)
46. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. A Yadava CF Ockenhouse, Infect Immun 2003 71 4961 4969 10.1128/IAI.71.9.4961-4969.2003 12933838 (Pubitemid 37070738)
47. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites. D Zhang W Pan, Infect Immun 2005 73 6530 6536 10.1128/IAI.73.10.6530- 6536.2005 16177327 (Pubitemid 41368817)
48. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. L Barfod NL Bernasconi M Dahlback D Jarrossay PH Andersen A Salanti MF Ofori L Turner M Resende MA Nielsen TG Theander F Sallusto A Lanzavecchia L Hviid, Mol Microbiol 2007 63 335 347 10.1111/j.1365-2958.2006.05503.x 17176260 (Pubitemid 46058923)
49. Chondroitin Sulfate A-Adhering Plasmodium falciparum-Infected Erythrocytes Express Functionally Important Antibody Epitopes Shared by Multiple Variants. L Barfod T Dobrilovic P Magistrado P Khunrae F Viwami J Bruun M Dahlback NL Bernasconi M Fried D John PE Duffy A Salanti A Lanzavecchia CT Lim NT Ndam MK Higgins L Hviid, J Immunol 2010 185 7553 61 10.4049/jimmunol.1002390 21078904
50. Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity. SR Elliott AK Brennan JG Beeson E Tadesse ME Molyneux GV Brown SJ Rogerson, Infect Immun 2005 73 5903 5907 10.1128/IAI.73.9.5903-5907. 2005 16113309 (Pubitemid 41193027)